CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

Company Overview - CG Oncology, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for bladder cancer patients [3] - The company aims to enhance the quality of life for urologic cancer patients through innovative immunotherapies [3] Upcoming Event - Management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference in New York on May 20, 2025, at 11:30 am ET [1] - Interested parties can access the live audio webcast from the Investor Relations section of the company's website, with a replay available for approximately 90 days post-event [2]